...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    gtbp-img

    GT Biopharma Inc, Common Stock

    GTBP

    NAQ

    $1.485

    +$0.15

    (11.19%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $4.39M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     88.43K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     1.33
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $0.96 L
    $4.1 H
    $1.485

    About GT Biopharma Inc, Common Stock

    GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 that targets B7-H3 on the surface of advanced solid tumors; and GTB-7550, a product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameGTBPSectorS&P500
    1-Week Return-14.66%4.54%1.2%
    1-Month Return-27.91%3.31%2.54%
    3-Month Return-33.71%1.37%8.18%
    6-Month Return-29.29%-5.75%5.2%
    1-Year Return-34%-11.44%15.01%
    3-Year Return-98.17%2.75%50.32%
    5-Year Return-98.24%26.82%90.12%
    10-Year Return-100%79.15%207.31%

    Financials

    Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
    Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Cost of Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Gross Profit-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Operating Expenses6.76M57.52M21.26M13.58M14.36M[{"date":"2020-12-31","value":11.76,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":36.96,"profit":true},{"date":"2023-12-31","value":23.6,"profit":true},{"date":"2024-12-31","value":24.97,"profit":true}]
    Operating Income(6.76M)(57.52M)(21.26M)(13.58M)(14.36M)[{"date":"2020-12-31","value":-676400000,"profit":false},{"date":"2021-12-31","value":-5751500000,"profit":false},{"date":"2022-12-31","value":-2125700000,"profit":false},{"date":"2023-12-31","value":-1357600000,"profit":false},{"date":"2024-12-31","value":-1436400000,"profit":false}]
    Total Non-Operating Income/Expense(24.85M)(1.18M)657.00K6.50M1.60M[{"date":"2020-12-31","value":-382.4,"profit":false},{"date":"2021-12-31","value":-18.13,"profit":false},{"date":"2022-12-31","value":10.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":24.68,"profit":true}]
    Pre-Tax Income(28.30M)(58.01M)(20.88M)(7.60M)(13.16M)[{"date":"2020-12-31","value":-2829600000,"profit":false},{"date":"2021-12-31","value":-5801300000,"profit":false},{"date":"2022-12-31","value":-2088400000,"profit":false},{"date":"2023-12-31","value":-759700000,"profit":false},{"date":"2024-12-31","value":-1316200000,"profit":false}]
    Income Taxes3.32M680.00K(381.00K)(13.58K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":20.48,"profit":true},{"date":"2022-12-31","value":-11.48,"profit":false},{"date":"2023-12-31","value":-0.41,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Income After Taxes(31.62M)(58.69M)(20.50M)(7.58M)-[{"date":"2020-12-31","value":-3161600000,"profit":false},{"date":"2021-12-31","value":-5869300000,"profit":false},{"date":"2022-12-31","value":-2050300000,"profit":false},{"date":"2023-12-31","value":-758342400,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
    Income From Continuous Operations(28.30M)(58.01M)(20.88M)(10.22M)(13.16M)[{"date":"2020-12-31","value":-2829600000,"profit":false},{"date":"2021-12-31","value":-5801300000,"profit":false},{"date":"2022-12-31","value":-2088400000,"profit":false},{"date":"2023-12-31","value":-1021900000,"profit":false},{"date":"2024-12-31","value":-1316200000,"profit":false}]
    Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income(28.30M)(58.01M)(20.88M)(7.60M)(13.16M)[{"date":"2020-12-31","value":-2829600000,"profit":false},{"date":"2021-12-31","value":-5801300000,"profit":false},{"date":"2022-12-31","value":-2088400000,"profit":false},{"date":"2023-12-31","value":-759700000,"profit":false},{"date":"2024-12-31","value":-1316200000,"profit":false}]
    EPS (Diluted)(3.57)(4.23)(0.67)(2.31)(7.02)[{"date":"2020-12-31","value":-357,"profit":false},{"date":"2021-12-31","value":-423,"profit":false},{"date":"2022-12-31","value":-67,"profit":false},{"date":"2023-12-31","value":-231,"profit":false},{"date":"2024-12-31","value":-702.32,"profit":false}]

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top